3.250USD-2.99%Mkt Cap: 192.81M $P/E: 1.721d ago
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringe…
Industry Peers
Medical Instruments & Supplies$122.33BUSDP/E 39.6
$83.33BUSDP/E 33.5
$70.90BUSDP/E 34.9
$43.58BUSDP/E 27.6
$31.56BUSDP/E 42.0
$28.86BUSDP/E 19.2
$25.31BUSDP/E 48.0
$19.64BUSDP/E 67.5
$18.05BUSDP/E 44.5
$18.27BUSDP/E 103.6
$14.52BUSDP/E 81.9
$13.88BUSDP/E 45.2
$14.08BUSDP/E 10.0
$13.99BUSDP/E 60.8
$12.66BUSDP/E 29.7
$11.68BUSD
$8.46BUSDP/E 22.7
$8.31BUSDP/E 161.8
$7.56BUSD
$5.67BUSDP/E 23.2
$5.96BUSDP/E 2692.2
$4.61BUSDP/E 31.0
$4.75BUSD
$4.41BUSDP/E 31.9
$4.35BUSDP/E 65.2
$4.00BUSDP/E 40.2
$3.94BUSDP/E 84.7
$3.63BUSDP/E 16.3
$3.36BUSDP/E 21.6
$3.24BUSDP/E 2641.0
$2.79BUSDP/E 21.4
$2.60BUSD
$2.81BUSD
$2.32BUSDP/E 37.4
$1.88BUSDP/E 33.0
$1.98BUSD
$1.77BUSD
$1.43BUSD
$1.42BUSD
$1.25BUSDP/E 62.5
$1.32BUSD
$1.21BUSD
$1.09BUSD
$822.54MUSD
$745.86MUSDP/E 15.9
$761.22MUSDP/E 14.9
$675.68MUSDP/E 39.4
$659.76MUSDP/E 55.8
$558.40MUSD
$354.63MUSDP/E 20.8
$350.60MUSDP/E 16.9
$266.44MUSD
$244.96MUSDP/E 13.5
$229.10MUSDP/E 416.7
$207.13MUSDP/E 34.9
$222.24MUSDP/E 20.7
$198.25MUSDP/E 23.8
$188.78MUSD
$183.20MUSDP/E 15.8
$151.41MUSD
$154.12MUSD
$121.82MUSDP/E 38.7
$115.11MUSD
$117.54MUSD
$106.20MUSD
$63.64MUSDP/E 6.6
$59.94MUSD
$47.50MUSD
$41.04MUSDP/E 54.0
$41.23MUSDP/E 41.0
$38.65MUSD
$32.66MUSD
$28.10MUSD
$25.49MUSDP/E 177.7
$20.49MUSD
$15.94MUSD
$14.75MUSD
$14.55MUSD
$13.20MUSD
$8.63MUSDP/E 14.8
$9.09MUSD
$6.92MUSD
$5.07MUSD
$4.35MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap192.81M $
Enterprise Value1.39B $
Revenue (TTM)1.04B $
Gross Profit676.80M $
Net Income (TTM)95.40M $
Revenue/Share17.74 USD
Last Price3.250 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees1.9K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)1.72
P/E (Forward)1.93
PEG—
EV/EBITDA4.17
EV/Revenue1.33
P/S0.19
P/B-0.32
EPS (TTM)1.89
EPS (Forward)1.74
52W Range
2.7704% of range15.55
52W High15.55 USD
52W Low2.770 USD
Profitability
Gross Margin62.64%
Oper. Margin19.34%
EBITDA Margin31.87%
Profit Margin8.83%
ROE-14.65%
ROA8.75%
Growth
Revenue Growth-14.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF191.70M $
CapEx (TTM)9.30M $
FCF Margin18.78%
FCF Yield101.55%
Net Debt1.19B $
Net Debt/EBITDA3.57
Balance Sheet
Debt/Equity-2.20
Current Ratio2.46
Quick Ratio1.34
Book Value/Sh-10.5530 USD
Cash/Share3.117 USD
Dividends
Fwd Div Rate0.4600 USD
Trail. Div Rate0.6000 USD
Div. Yield14.24%
5Y Avg Yield—
Payout Ratio31.75%
Ex-Div DateMay 28, 2026
Pay DateJun 15, 2026
Analyst Consensus
Rating3.3 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+23.1%
Target Range3.000 USD – 5.000 USD
$3.000+23.1% to mean$5.000
# Analysts2
Ownership
Shares Out.59.33M
Float58.33M
Insiders1.74%
Institutions100.57%
Short Interest
Short Ratio2.3d
Short % Float11.74%
Short % Out.9.85%
Shares Short5.85M
Short (prev mo.)7.41M
Technical
SMA 503.387 (-4.0%)
SMA 2009.461 (-65.6%)
Beta0.81
S&P 52W Chg20.25%
Avg Vol (30d)2.14M
Avg Vol (10d)1.56M
Technical Indicators
RSI (14)44.9
MACD-0.1217
MACD Signal-0.1802
MACD Hist.+0.0585
BB Upper3.469 USD
BB Middle3.227 USD
BB Lower2.985 USD
BB Width15.00%
ATR (14)0.1811 USD
Vol Ratio (20d)0.43x